Part11Solutions

  The pharmaceutical and life sciences sectors are currently a major transformation in the way that technology supports manufacturing. As AI and ML technologies are transitioning from research labs to production facilities, regulators have bodies in to keeps in mind that innovation does not put safety at risk. The publication of the Annex 22 guideline is a represents a landmark moment in this journey, being the first well, articulated framework of how AI can be used in good manufacturing practice (GMP) environments. Understanding the nuances of Annex 22 is no longer optional for Quality Assurance (QA) groups and information scientists; it's a fundamental requirement for final compliant in an increasingly automated world.   Overview of Annex 22 Applicability to AI Models Annex 22 was created to fill the void left by old regulations, like Annex 11, which were mainly concerned with traditional computer...

  Computer Systems Validation is costly and time-consuming for life science companies. CIMCON’s Validation as a Service™ uses AIValidator™ to automatically generate URS, IQ, OQ, and RTM documents, reducing validation costs and accelerating project timelines. Visit:  https://part11solutions.com/validation-as-a-service-vaas/

  eInfotree EDMS Solution delivers powerful document-controls with secure SQL/Oracle file vaults, check-in/check-out, full version control, audit trails, e-signatures, multi-level security, global web access, and advanced password management. Visit:  https://part11solutions.com/document-controls/

  This annex outlines guidance for using AI/ML models in GMP manufacturing of medicines and active substances. It applies to static, deterministic models used in critical applications, excluding dynamic, probabilistic, and generative AI like LLMs. Visit:  https://part11solutions.com/euc-annex-22-on-ai/

  Access databases play a vital role in GxP applications such as batch records, clinical data, and manufacturing logs. However, without proper controls, they risk data integrity issues. To meet FDA requirements, Access databases must be fully 21 CFR Part 11 compliant. Visit:  https://part11solutions.com/einfotree-access-module/

  In today's fast-paced business environment, organizations rely closely on documentation to manage methods, ensure compliance, and make important choices. From complex engineering specs and financial reviews to standard running approaches (SOPs) and customer contracts, the accuracy of these files is paramount. Errors, however minor, can cause substantial consequences-economic loss, regulatory non-compliance, reputational damage, or operational screw ups. This is in which Document Controls -the systematic management of files at some point of their lifecycle-come to be fundamental. Implementing robust and powerful record manage measures isn't just a regulatory necessity; it is a strategic vital for minimizing errors and improving the overall accuracy and integrity of organizational records. Common Causes of Errors in Documents Understanding the root causes of document inaccuracies is the first step toward creating preventative measures. Errors often don't stem from a sin...